Treatment for Advanced Soft Tissue Sarcoma

The treatment of soft tissue sarcomas (STSs), which encompass a group of more than 70 histologically and biologically distinct subtypes of cancer, is emblematic of an orphan disease. About 13  000 patients are diagnosed as having STS in the United States every year, survival rates are poor and have not changed in the last 40 years, and there is little funding to support scientific discovery of disease biology to improve treatment regimens. Clinical presentation and prognosis are influe nced not only by the extent of disease and histological subtypes, but by tumor location as well. There is a significant unmet need for improved systemic therapies in the treatment of patients with STS.
Source: JAMA - Category: General Medicine Source Type: research